XML 37 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of valuation of the company's investments and financial instruments that are measured at fair value on a recurring basis
The following table summarizes the valuation of the Company’s financial instruments that are measured at fair value on a recurring basis:

 September 30, 2025December 31, 2024
  Fair value measurement category Fair value measurement category
(In thousands)TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Assets:
Money market funds$42,257 $42,257 $— $— $43,307 $43,307 $— $— 
Commercial paper2,950 — 2,950 — 1,953 — 1,953 — 
Corporate notes71,597 — 71,597 — 71,763 — 71,763 — 
U.S. government agency bonds10,094 — 10,094 — 7,857 — 7,857 — 
U.S. government securities (a)
47,239 — 47,239 — 16,150 — 16,150 — 
$174,137 $42,257 $131,880 $— $141,030 $43,307 $97,723 $— 
Liabilities:
Deferred compensation plan liabilities$1,389 $— $1,389 $— $306 $— $306 $— 
Total liabilities$1,389 $— $1,389 $— $306 $— $306 $— 
(a) Approximately $47.2 million and $16.2 million of U.S. government securities had an original maturity of 90 days or less and were recorded as a cash equivalent as of September 30, 2025 and December 31, 2024, respectively.